MyDRUG Evaluates Targeted Agents in Multiple Myeloma
Investigators are taking a personalized approach to treating patients with multiple myeloma by introducing novel agents in combination with backbone chemotherapies, based on patients’ individual genetic profiles.
Source: OncLive